Alzheimer's disease, a progressive neurodegenerative disorder, presents varying prognoses influenced by several factors. Age is a primary determinant, with risk increasing significantly after 65 years. Genetic predispositions, such as the APOE ε4 allele, elevate susceptibility. Lifestyle factors like cardiovascular health and education level also play roles; poor cardiovascular health can exacerbate cognitive decline, while higher education levels appear protective. Neuroimaging studies reveal brain atrophy patterns and amyloid-beta deposits, aiding in prognostication. Additionally, early symptom severity and the rate of cognitive decline are crucial indicators. Advances in biomarker research, including cerebrospinal fluid analyses and PET scans, offer promising tools for predicting disease progression. Understanding these multifaceted prognostic factors is crucial for improving diagnostic accuracy, developing targeted interventions, and ultimately enhancing outcomes for Alzheimer's patients.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States